Methods of quantification for PET studies of human NK1 receptors with [18F]SPA-RQ

被引：0
|
作者：
Hinz, R
Hafizi, S
Bhagwagar, Z
Hargreaves, R
Grasby, PM
机构：
[1] Hammersmith Imanet Ltd, London, England
[2] MRC, Ctr Clin Sci, London, England
[3] Univ Oxford, Dept Psychiat, Oxford OX1 2JD, England
[4] Univ Oxford, Dept Pharmacol, Oxford OX1 2JD, England
[5] Merck Res Labs, W Point, PA USA
来源：
NEUROIMAGE | 2004年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：T75 / T76
页数：2
相关论文
共 50 条
  • [31] PET studies of [18F]norchlorofluoroepibatidine in mapping nicotinic acetylcholine receptors (nAChR).
    Ding, YS
    Fowler, JS
    Gatley, SJ
    Volkow, ND
    Logan, J
    Dewey, SL
    Liang, F
    Carroll, FI
    Kuhar, MJ
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 295 - 295
  • [32] Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET:: an equilibrium approach
    Meyer, PT
    Elmenhorst, D
    Bier, D
    Holschbach, MH
    Matusch, A
    Coenen, HH
    Zilles, K
    Bauer, A
    NEUROIMAGE, 2005, 24 (04) : 1192 - 1204
  • [33] Evaluation of [18F]AZAN for quantification of nicotinic acetylcholine receptors in human brain
    Kuwabara, Hiroto
    Horti, Andrew
    Brasic, James
    Gao, Yongjun
    Guevara, Maria Rita
    Zaidi, Eram
    Wong, Dean
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [34] [18F]fluoroethylflumazenil:: a novel tracer for PET imaging of human benzodiazepine receptors
    Gründer, G
    Siessmeier, T
    Lange-Asschenfeldt, C
    Vernaleken, I
    Buchholz, HG
    Stoeter, P
    Drzezga, A
    Lüddens, H
    Rösch, F
    Bartenstein, P
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (10) : 1463 - 1470
  • [35] [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors
    Gerhard Gründer
    Thomas Siessmeier
    Christian Lange-Asschenfeldt
    Ingo Vernaleken
    Hans-Georg Buchholz
    Peter Stoeter
    Alexander Drzezga
    Hartmut Lüddens
    Frank Rösch
    Peter Bartenstein
    European Journal of Nuclear Medicine, 2001, 28 : 1463 - 1470
  • [36] PET quantification of 5-HT2A receptors in the human brain:: A constant infusion paradigm with [18F]altanserin
    van Dyck, CH
    Tan, PZ
    Baldwin, RM
    Amici, LA
    Garg, PK
    Ng, CK
    Soufer, R
    Charney, DS
    Innis, RB
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (02) : 234 - 241
  • [37] INVESTIGATION ON THE SYNTHESIS AND WORKUP OF [18F]FLUMAZENIL FOR HUMAN PET STUDIES
    Massarweh, G.
    Schirrmacher, E.
    Kovacevic, M.
    Waengler, C.
    La Fougere, C.
    Thiel, A.
    Schirrmacher, R.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S287 - S287
  • [38] Comparison of [18F]altanserin and [18F]deuteroaltanserin for PET imaging of serotonin2A receptors in baboon brain:: pharmacological studies
    Staley, JK
    Van Dyck, CH
    Tan, PZ
    Al Tikriti, M
    Ramsby, Q
    Klump, H
    Ng, C
    Garg, P
    Soufer, R
    Baldwin, RM
    Innis, RB
    NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (03) : 271 - 279
  • [39] PET assessment of human cerebral tau deposition using [18F]AV-1451-comparison of quantification methods
    Chen, Yin
    Mankoff, David
    Nasrallah, Ilya
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [40] Evaluation of [18F]-(-)-norchlorofluorohomoepibatidine ([18F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates
    Bois, Frederic
    Gallezot, Jean-Dominique
    Zheng, Ming-Qiang
    Lin, Shu-Fei
    Esterlis, Irina
    Cosgrove, Kelly P.
    Carson, Richard E.
    Huang, Yiyun
    NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (06) : 570 - 577
12345